Table 3.
Primary and Secondary Outcomes – Obese Cohort
| All (n=407) | PIV (n = 320) | IO (n = 87) | OR (95% CI) | p-Value | |
|---|---|---|---|---|---|
| 
 | |||||
| Primary Outcome | |||||
| Survival to hospital discharge, n (%) | 91 (22.3) | 75 (23.4) | 16 (18.4) | 0.91 (0.48 – 1.73) | 0.77 | 
| Secondary Outcomes | |||||
| Survival with favourable neurologic status, n (%) | 81 (19.9) | 68 (21.3) | 13 (15.9) | 0.94 (0.48 – 1.86) | 0.86 | 
| ROR, n (%) | 325 (79.8) | 261 (81.6) | 64 (73.6) | 0.73 (0.41 – 1.31) | 0.30 | 
| TTR, min ± SD | 10:44 ± 9:58 | 9:56 ± 9:22 | 13:58 ± 11:38 | -- | <0.01 | 
Primary and secondary outcomes for a subgroup of individuals with obesity, defined as BMI ≥ 30kg/m2 Odds ratios and p-values are adjusted for age, gender, initial rhythm, witnessed status and time-to-epinephrine.
IO = intraosseous; PIV = peripheral Intravenous; ROR = Rate-of-ROSC; TTR = Time-to-ROSC.